Focal Biosciences

Private

VilligenHealthcare & Life Scienceshttps://focalbiosciences.com/

Last Round

Seed

Oct 11, 2022

Company Overview

Focal Biosciences is a biotechnology company that develops a cellular reprogramming discovery platform to identify small-molecule therapeutics for age-related chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

cellular reprogrammingdrug discoverymechanobiologyAI drug discoveryCFC platformchromatin fingerprintsmall-molecule therapeuticshigh-content imagingin silico drug discoveryepigenetic modulatorsage-related diseasesphenotypic screeningbiotech startupcomputational biologylongevity biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Focal Biosciences Comparables

Compare Focal Biosciences with similar companies based on industry and business-model similarity.

Focal Biosciences comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Clock.bio	85%
TippingPoint Biosciences	81%
Forcyte Biotechnologies	77%

View all Comparables

Focal Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Oct 11, 2022

View all Funding Rounds

Focal Biosciences Investors

Notable investors and investment history

Focal Biosciences investors
Investor	Rounds
Paul Scherrer Institute	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 11, 2022
Seed round with participation from Paul Scherrer Institute.

View all signals

Focal Biosciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Focal Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Focal Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersVilligen

Employee Range2

Year Founded2022

Last FundingOct 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?